Related Articles
Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway
Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cells
Gene expression profiling predicts response to temozolomide in malignant gliomas
miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP-α in glioblastoma
Combination of temozolomide and Taxol exerts a synergistic inhibitory effect on Taxol‑resistant glioma cells via inhibition of glucose metabolism